The FINANCIAL — Takeda Pharmaceutical Company Limited ("Takeda") on March 23 announced that it has signed an agreement with Wyeth for the product licence for Prostap (leuprorelin acetate), an LH-RH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback